Medtronic today shared new, long-term data demonstrating the clinical benefit of its Symplicity Spyral renal denervation (RDN) system. Symplicity Spyral delivers radiofrequency energy to nerves near the kidneys in a minimally invasive procedure to treat hypertension. These nerves can become overactive and contribute to high blood pressure. The … [Read more...] about Medtronic data highlights clinical benefit of Symplicity Spyral renal denervation
Technologies & Devices
Medtronic makes neurovascular play with $550M Scientia Vascular buy
Medtronic (NYSE: MDT) announced today that it entered into a definitive agreement to acquire Scientia Vascular in a deal valued at $550 million. Salt Lake City, Utah-based Scientia Vascular develops access products for treating complex neurovascular conditions. Its portfolio features guidewires and catheters that Medtronic can seamlessly … [Read more...] about Medtronic makes neurovascular play with $550M Scientia Vascular buy
Stereotaxis expects growth in 2026 with manufacturing ramp for new products
Stereotaxis (NYSE:STXS) today reported its fourth-quarter and full-year financial results ahead of expected growth in 2026. The company reported fourth-quarter revenue totaling $8.6 million, marking a 36% increase year-over-year. However, that fell shy of Wall Street expectations for $9.24 million. St. Louis-based Stereotaxis reported total 2025 … [Read more...] about Stereotaxis expects growth in 2026 with manufacturing ramp for new products
Pulse Biosciences has positive data for thyroid nodule ablation
Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system. Long-term follow-up data came from the nPulse Vybrance percutaneous electrode system first-in-human ablation study. It evaluated the ablation of benign thyroid nodules using nanosecond pulsed field ablation (nsPFA) … [Read more...] about Pulse Biosciences has positive data for thyroid nodule ablation
BD picks up CE mark for Revello vascular covered stent
BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system. Franklin Lakes, New Jersey–based BD designed Revello to treat atherosclerotic lesions in the common and external iliac arteries. The next-generation endovascular solution combines the flexibility of a nitinol self-expanding stent with … [Read more...] about BD picks up CE mark for Revello vascular covered stent
Airiver Medical wins FDA breakthrough nod for drug-coated balloon, treats first patient
Airiver Medical announced today that it received FDA breakthrough device designation for its pulmonary drug-coated balloon (DCB). Additionally, Airiver announced the first treated patients in a clinical trial for the DCB. The Brooklyn Park, Minnesota-based company designed its DCB to treat central airway stenosis. Central airway stenosis … [Read more...] about Airiver Medical wins FDA breakthrough nod for drug-coated balloon, treats first patient
CereVasc reports first-in-human use of eShunt for idiopathic intracranial hypertension
CereVasc today announced the first-in-human case report for the use of its eShunt system to treat medically refractory idiopathic intracranial hypertension (IIH). IIH, formerly known as pseudotumor cerebri, is characterized by elevated pressure around the brain without an identifiable structural cause. The condition is associated with chronic … [Read more...] about CereVasc reports first-in-human use of eShunt for idiopathic intracranial hypertension
Boston Scientific wins expanded CE mark for Farapulse in persistent AFib
Boston Scientific (NYSE: BSX) announced today that its Farapulse pulsed field ablation (PFA) system received expanded CE mark approval. The PFA system earned expanded labeling in Europe to include the treatment of persistent AFib, according to a LinkedIn post. "This approval represents an important step forward in addressing the evolving … [Read more...] about Boston Scientific wins expanded CE mark for Farapulse in persistent AFib
Johnson & Johnson Medtech launches new CereGlide aspiration catheters in US
Johnson & Johnson MedTech announced today that it launched its CereGlide 42 and CereGlide 57 aspiration catheters in the U.S. The medtech giant also launched the InnerGlide 7 delivery aid, rounding out the newest additions to its aspiration-first stroke portfolio. J&J MedTech said the devices complete the CereGlide family, which … [Read more...] about Johnson & Johnson Medtech launches new CereGlide aspiration catheters in US
Olympus picks up pediatric indications from FDA for duo of single-use bronchoscopes
Olympus announced today that it received FDA clearance for pediatric use for two of the single-use bronchoscopes it distributes in the U.S. Center Valley, Pennsylvania-based Olympus Corp. of the Americas distributes the H-SteriScope single-use video flexible bronchoscopes in the U.S. Hunan Vathin Medical Instrument Co. manufactures the scopes. … [Read more...] about Olympus picks up pediatric indications from FDA for duo of single-use bronchoscopes
